(Q50944101)

25 March 2018

title

Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. (English)

1 reference

25 March 2018

Adaptive radiation therapy

main subject

0 references

1 reference

Wharam MD

1

1 reference

25 March 2018

Hanfelt JJ

2

1 reference

25 March 2018

Tefft MC

3

1 reference

25 March 2018

Johnston J

4

1 reference

25 March 2018

Ensign LG

5

1 reference

25 March 2018

Breneman J

6

1 reference

25 March 2018

Donaldson SS

7

1 reference

25 March 2018

Fryer C

8

1 reference

25 March 2018

Gehan EA

9

1 reference

25 March 2018

Raney RB

10

1 reference

25 March 2018

Maurer HM

11

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

25 March 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

25 March 2018

volume

38

1 reference

25 March 2018

issue

4

1 reference

25 March 2018

page(s)

797-804

1 reference

25 March 2018

The future of therapy for childhood rhabdomyosarcoma: Clues from molecular biology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

The Third Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Local control of embryonal rhabdomyosarcoma in children by radiation therapy when combined with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Local failure in childhood rhabdomyosarcoma and undifferentiated sarcoma: prognostic factors and implications for curative therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

The Intergroup Rhabdomyosarcoma Study-I. A final report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

The Intergroup Rhabdomyosarcoma Study-II.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

Pediatric orofacial and laryngopharyngeal rhabdomyosarcoma. An Intergroup Rhabdomyosarcoma Study report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900120-X

7 January 2021

10.1016/S0360-3016(97)00120-X

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018